Homebiotech

biotech

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026

biotech

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

Jim Cornall - April 30, 2026

biotech

Aragen launches India’s first women-led chemistry synthesis laboratory

Jim Cornall - April 30, 2026

biotech

Vaccine strategy induces broadly neutralising HIV antibodies

Jim Cornall - April 30, 2026

biotech

Video: Lithuanian company Caszyme at forefront of gene editing

Jim Cornall - November 14, 2023

biotech

Kuano raises £1.8M to accelerate quantum drug discovery

Jim Cornall - September 14, 2023

biotech

Intellegens and CPI receive grant to advance manufacture of oligonucleotide therapeutics with machine learning

Jim Cornall - August 31, 2023

biotech

10 Lithuanian startups to watch

Jim Cornall - July 30, 2023

biotech

Revolutionary self-sensing electric artificial muscles

Jim Cornall - July 18, 2023

biotech

Using DNA for data storage

Jim Cornall - July 18, 2023

1...71 7273Page 73 of 73

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026 0

This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about...

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

biotech Jim Cornall - April 30, 2026 0

Aragen launches India’s first women-led chemistry synthesis laboratory

biotech Jim Cornall - April 30, 2026 0

Vaccine strategy induces broadly neutralising HIV antibodies

biotech Jim Cornall - April 30, 2026 0

New target for cancer treatment

biotech Jim Cornall - April 29, 2026 0